Skip to main content
CELC logo

CELC · Celcuity Inc. · Metrics

Track CELC — free
$56.48 +0.88 (+1.58%) Play latest call Q3 2026 earnings call transcript
Market Cap
$2.73B
Shares
49.13M
Volume · Nov 19 86.28K Avg daily vol (3M) 1.23M

CELC metrics

60 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$55.60
Market cap
$2.73B

Price action

23 metrics
Price change (1W)
-13.6%
Price change (30D)
-2.7%
Price change (3M)
-40.6%
Price change (6M)
-60.4%
Price change (YTD)
-44.3%
Price change (1Y)
-39.3%
Trailing year
Price change (5Y)
+244.7%
52-week high
$144.98
52-week low
$55.60
Change from 52-week high
-61.6%
Change from 52-week low
+0.0%
Annualized volatility
63.6%
Annualized volatility (3M)
54.9%
Implied volatility (30D)
68.7%
IV rank (1Y)
45.3
IV percentile (1Y)
32.9
Beta
1.2
RSI (14D)
31.7
Price vs SMA 50
-21.0%
Price vs SMA 200
-43.1%
Avg volume (3M)
1.23M
Relative volume
0.8
Average dollar volume
$88.18M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
49.13M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
—
FCF yield
-7.8%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-9.4%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-11-05

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$243.15M
Net income (TTM)
−$256.01M
Trailing 12 months
Diluted EPS (TTM)
$-4.71
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$2.08

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+15.9%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-35.2%
Debt / equity
—
Current ratio
14.6
EBITDA (TTM)
—
Free cash flow (TTM)
−$213.48M
Quick ratio
14.6
Interest coverage
-11.9
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$642.70M
Latest balance sheet
Cash & equivalents
$178.16M
Total assets
$726.87M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$213.12M
Capital expenditures (TTM)
$364,000
R&D (TTM)
$150.06M
SG&A (TTM)
—
Stock compensation (TTM)
$31.71M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
269
13F filer change QoQ
-5
Institutional ownership
117.8%
Conviction holders (share of 13F filers)
4.8%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+1.2%
Holder tenure
9.5
Price vs estimated holder cost
+9.5%

Ownership (registered funds)

1 metrics
Index-fund ownership
13.0%

Short interest

3 metrics
Short interest
21.0%
Latest settlement · 5.9 days to cover
Days to cover
5.9d
Short-squeeze score
76 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1603454 CUSIP 15102K100 13F (30d) 273 filings 259 filers Visit website Investor relations